Response Report to the Audit Inquiry Letter on Orient Pharmaceutical Co., Ltd.'s Application Documents for Issuance of Convertible Corporate Bonds to Unspecified Targets (2023 Financial Data Update)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.